Enhanced gamma interferon production through activation of Vα14+ natural killer T cells by α-Galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis

Infection and Immunity

Volumn 69, Issue 11, 2001, Pages 6643-6650

  Kawakami, K ^a   Kinjo, Y ^a   Yara, S ^a   Uezu, K ^a   Koguchi, Y ^a   Tohyama, M ^a   Azuma, M ^a   Takeda, K ^a   Akira, S ^a   Saito, A ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSYLCERAMIDE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 4; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; RECOMBINANT INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; HOST RESISTANCE; KNOCKOUT MOUSE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TH1 CELL;

ANIMALS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; GALACTOSYLCERAMIDES; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-18; INTERLEUKIN-4; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES; TH1 CELLS;

EID: 0034772910     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.11.6643-6650.2001     Document Type: Article

References (48)

1. Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates
2. Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells
3. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors
4. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer cells
5. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells
6. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans
7. + effector function against intracellular infection
8. IL-18: A Th1-inducing, proinflammatory cytokine and new member of the IL-1 family
9. Rapid death and regeneration of NKT cells in anti-CD3e-or IL-12-treated mice: A major role for bone marrow in NKT cell homeostasis
10. α-galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria
11. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells
12. Lipid antigen presentation in the immune system: Lessons learned from CD1d knockout mice
13. IL-18 is a potent coinducer of IL-13 in NK and T cell: A new potential role for IL-18 in modulating the immune response
14. + T cells
15. + Vαl4 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major
16. Natural ligand of mouse CD1d1: Cellular glycosylphosphatidylinositol
17. IL-4 is a mediator of IL-12p70 induction by human Th2 cells: Reversal of polarized Th2 phenotype by dendritic cells
18. Interleukin-4 and listeriosis
19. Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: Effects of interleukin-12
20. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production
21. Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-γ-inducing cytokines
22. Reduced host resistance and Th1 response to Cryptococcus neoformans in interleukin-18 deficient mice
23. IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells
24. l4+ natural killer T cells by α-galactosylceramide results in the development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans
25. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides
26. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells
27. High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10
28. A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement
29. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: A pro-Th2 effect of IL-18 exerted through NKT cells
30. Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium
31. + T helper type 1 cell responses to Candida albicans
32. The expanding universe of T-cell subsets: Th1, Th2 and more
33. Potentiality of interleukin-18 as a useful reagent for treatment and prevention of Leishmania major infection
34. Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide
35. Early induction of interleukin-12 by human monocytes exposed to Cryptococcus neoformans mannoprotein
36. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFKB
37. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells
38. T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice
39. Activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype
40. Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines
41. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit
42. + αβ T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis
43. Defective NK cell activity and Th1 response in IL-18-deficient mice
44. Inhibition of experimental tumor metastasis by dendritic cells pulsed with α-galactosylceramide
45. Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice
46. The route of inoculation can determine the resultant murine immune response to Cryptococcus neoformans strain 52D
47. Influence of molecular sizes of Cryptococcus neoformans capsular polysaccharide on phagocytosis
48. IL-18, although anti-allergic when administered with IL-12, stimulates IL-4 and histamine release by basophils